MacroGenics, Inc. (NASDAQ: MGNX) has completed the sale of its good manufacturing practice (GMP) drug substance manufacturing operations to Bora ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Mergers and Acquisitions